BAM15: A Novel Mitochondrial Uncoupler for Metabolic Research and Therapeutic Applications
Discover the groundbreaking potential of BAM15 in revolutionizing metabolic research and treating a spectrum of diseases.
Get a Quote & SampleProduct Core Value
BAM15
BAM15 is a cutting-edge mitochondrial uncoupler that selectively targets mitochondria to promote energy expenditure. This small molecule is a powerful tool for studying obesity, diabetes, and metabolic disorders, offering a superior safety profile and tissue specificity in preclinical models.
- Promotes fat loss studies: BAM15 promotes uncoupling protein-independent thermogenesis, aiding in BAM15 obesity treatment.
- Supports metabolic disease research: It improves insulin sensitivity and glucose homeostasis, crucial for BAM15 diabetes management.
- Enhances aging interventions: BAM15 improves mitochondrial function and cellular health.
- Offers anti-cancer properties: BAM15 has shown promise in BAM15 cancer therapy by inducing apoptosis and inhibiting proliferation.
Key Advantages
Enhanced Energy Expenditure
BAM15 uncouples oxidative phosphorylation, leading to increased mitochondrial respiration and energy expenditure, crucial for understanding mitochondrial uncouplers mechanism of action.
Improved Insulin Sensitivity
Preclinical studies indicate that BAM15 can effectively reverse insulin resistance across various tissues, supporting its role in metabolic disease management.
Favorable Safety Profile
Compared to traditional uncouplers, BAM15 demonstrates reduced cytotoxicity and off-target effects, making it a promising candidate for BAM15 drug development.
Key Applications
Metabolic Research
BAM15 is a valuable tool for researchers investigating mitochondrial function and its role in various metabolic conditions, including obesity and diabetes.
Obesity Treatment
By increasing energy expenditure and reducing fat accumulation, BAM15 offers a potential therapeutic strategy for managing obesity.
Diabetes Management
BAM15's ability to improve insulin sensitivity and glucose homeostasis positions it as a potential agent for diabetes treatment.
Cancer Therapy
BAM15 shows promise in suppressing cancer growth and proliferation by targeting mitochondrial metabolism and inducing apoptosis.